Why Innate Pharma Shares Are Rising On Friday?
Innate Pharma SA (NASDAQ:IPHA) stock closed almost 14% higher on Thursday after the Company disclosed two upcoming presentations scheduled at ESMO…
‘Health Officials Advise White House to Scale Back Booster Plan for Now’ -New York Times
https://www.nytimes.com/2021/09/03/us/coronavirus-booster-shots.html?searchResultPosition=1
AstraZeneca’s Ultomiris Scores European Nod For Rare Blood Disorder In Kids, Adolescents
The European Commission has approved Alexion’s Ultomiris (ravulizumab) paroxysmal nocturnal hemoglobinuria (PNH) in children (with a bodyweight of 10 kg…
EMA Reviewing Cases Of Multisystem Inflammatory Syndrome After Pfizer COVID Shot
Europe Medicines Agency (EMA) said it is reviewing cases of the multisystem inflammatory syndrome (MIS) after inoculation with COVID-19 vaccines,…
AstraZeneca, EU Reach Settlement On COVID-19 Vaccine Delivery
AstraZeneca Plc (NASDAQ:AZN) and the European Commission have settled on the delivery of pending COVID-19 vaccine doses by the Company. The…
White House Commits $3B To Boost COVID-19 Vaccine Supply Chain: Report
The U.S. will invest $3 billion in the COVID-19 vaccine supply chain within the coming weeks, White House coronavirus response…
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 2)
AstraZeneca, European Commission Reach Settlement Agreement Over Vaccine Supply, Ending Litigation; AstraZeneca Commits to Deliver 60M by the End Q3 2021, 75M by the End of Q4 2021, 65M by the End of Q1 2022
AstraZeneca (NYSE: AZN) and the European Commission have reached an agreement that ends legal proceedings over the execution of the Advance Purchase Agreement for the delivery of the COVID-19 vaccine Vaxzevria (ChAdOx1-S [Recombinant]).